VR1
New York, US · Founded 2012
Founders & leadership
MH
Michele HarrisExecutive
AC
Anjan ChatterjeeExecutive
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 2 rounds · 2013–2014
▶$900.3KraisedSep 2014 · 7 investors · PharmaceuticalsRule 506(b)
▶$900.3KraisedSep 2014 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anjan ChatterjeeExecutive Officer, Director
- Michele HarrisExecutive Officer, Director
- Offering amount
- $930.3K
- Amount sold
- $900.3K
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$335KraisedMay 2014 · 10 investors · PharmaceuticalsRule 506(b)
▶$335KraisedMay 2014 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michele HarrisExecutive Officer, Director
- Anjan ChatterjeeExecutive Officer, Director
- Offering amount
- $335K
- Amount sold
- $335K
- First sale
- Oct 2013
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has VR1 raised?
- VR1 has disclosed $1.2M raised across 2 rounds.
- Where is VR1 headquartered?
- VR1 is headquartered in New York, US.